Reaxing
Complete solutions for the Neuroreactive Training in PERFORMANCE and MEDICAL fields.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | N/A | Late VC | |
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 173 % | 52 % | (58 %) | 52 % | 9 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (62 %) | 9 % | 17 % | (21 %) | 14 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (63 %) | (2 %) | 4 % | (27 %) | 11 % | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Reaxing operates in the niche market of neuroreactive training, providing innovative solutions for both performance enhancement and medical rehabilitation. The company serves athletes, fitness enthusiasts, and medical professionals who seek advanced training methodologies to improve cognitive, proprioceptive, and neurofunctional abilities. Reaxing's business model revolves around the sale of patented training equipment and software, which deliver sudden sensory impulses to stimulate rapid physical and mental responses. Revenue is generated through direct sales, training courses, and certifications. The company leverages its unique technology to offer an unparalleled training experience, supported by an integrated app for customizable workout programs.
Keywords: Neuroreactive, Training, Performance, Rehabilitation, Cognitive, Proprioceptive, Patented, Equipment, Software, Customizable.